Complexo Hospitalario Universitario de Vigo
Centro de atención
Pfizer (United States)
Nueva York, Estados UnidosPublicacións en colaboración con investigadores/as de Pfizer (United States) (8)
2023
-
Pneumococcal Serotypes Associated with Community-Acquired Pneumonia Hospitalizations in Adults in Spain, 2016–2020: The CAPA Study
Microorganisms, Vol. 11, Núm. 11
2022
-
Clinical Factors Associated With Long-Term Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Axitinib: Real-World AXILONG Study
Clinical Genitourinary Cancer, Vol. 20, Núm. 1, pp. 25-34
-
Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study)
Lung Cancer, Vol. 173, pp. 83-93
2017
-
Circulating antibody 1 and 2 years after vaccination with the 13-valent pneumococcal conjugate vaccine in preterm compared with term infants
Pediatric Infectious Disease Journal, Vol. 36, Núm. 3, pp. 326-332
2016
2015
-
13-Valent pneumococcal conjugate vaccine (PCV13) in preterm versus term infants
Pediatrics, Vol. 135, Núm. 4, pp. e876-e886
2011
-
Clinical utility of maraviroc
Clinical Drug Investigation, Vol. 31, Núm. 8, pp. 527-542
2007
-
Impacto de la EPOC en la vida diaria de los pacientes. Resultados del estudio multicéntrico EIME
Archivos de Bronconeumologia, Vol. 43, Núm. 2, pp. 64-72